Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06581523 · ClinicalTrials.gov registry record · NA

Efficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care Partners

A NA study of Parkinson's Disease, sponsored by Nova Southeastern University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
3
Study locations

NCT06581523: Recruiting NA study of Parkinson's Disease, sponsored by Nova Southeastern University.

NCT06581523 is a NA study of Parkinson's Disease that is actively recruiting participants, run by Nova Southeastern University. The registered enrollment target is 40 participants, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (94% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06581523, a NA study of Parkinson's Disease, is actively recruiting participants, sponsored by Nova Southeastern University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
3
Study locations

Study Summary

The goal of this feasibility study and clinical trial is to learn if an evidenced-based breathwork and meditation intervention (SKY Breath) will improve the mental and physical well-being of individuals with Parkinson's Disease (iPD) in stages 1, 2, and 3, under the age of 75 and their care partners. The main questions it aims to answer are: * Objective 1: Can the SKY Breath practice be designed and implemented to specifically cater to the unique needs of individuals with Parkinson's Disease and their care partners. * Objective 2: Will the SKY Breath practice decrease stress levels (a contributor to increasing PD symptoms) for individuals with Parkinson\'s Disease (iPD) and their care partners as measured through self-reported surveys to improve overall well-being and quality of life. * Objective 3: Will the SKY Breath practice in part alleviate the emotional stress and physical burden experienced by care partners of PD patients, promoting their resilience and well-being. Participants will be asked to learn the SKY Breath and Meditation practice over the course of 4 days (2.25 hours each morning), practice SKY every day for 4 weeks and keep a log of time spent doing SKY. The participants will complete a series of surveys before learning the practice and then after at weeks 1, 4 and 8. The series of surveys will take about 20 minutes.

Primary Outcome

Improving the feelings of pressure and overwhelm measured before and after intervention from self-reported stress scales. Individuals with Parkinson's Disease evaluated on: * Parkinson's Disease Anxiety Scale- Scoring 0-48. Higher score=greater anxiety. * Perceived Stress Scale (PSS) -Scores from 0-40; higher scores=higher perceived stress.

Conditions Studied

Interventions

  • BEHAVIORAL SKY Breath and Meditation

Study Locations (3)

Florida

  • Raw Kickboxing and Fitness - Coral Springs
  • David Posnack Jewish Community Center - Davie
  • Nova Southeastern University - Fort Lauderdale

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-10-19
Est. Completion 2026-04-30
Phase NA
Nova Southeastern University

71 total trials

What NCT06581523 shows while recruiting

NCT06581523 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which SKY Breath and Meditation is the first listed.

NCT06581523 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06581523 about?

NCT06581523 is a clinical study titled "Efficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care Partners". The goal of this feasibility study and clinical trial is to learn if an evidenced-based breathwork and meditation intervention (SKY Breath) will improve the mental and physical well-being of individuals with Parkinson's Disease (iPD) in stages 1, 2, and 3, under the age of 75 and their care partners...

What is the current status of trial NCT06581523?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-10-19. Estimated completion is 2026-04-30.

What conditions does trial NCT06581523 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT06581523?

The interventions under investigation include: SKY Breath and Meditation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06581523?

This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06581523 being conducted?

This trial has 3 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06581523's enrollment target sits among peer trials

40 92nd of 158 higher than 63 of 158 other Parkinson's Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06581523, the US trial registry maintained by the National Library of Medicine. NCT06581523 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.